Journal articleCancer Lett2023
ENT1 blockade by CNX-774 overcomes resistance to DHODH inhibition in pancreatic cancer.
- Journal
- Cancer Lett
- Published
- 27 October 2022
- Citations
- 27
- Type
- Article
These are bibliographic fields. A study card, with population, design, endpoints and result direction each tied to a quote, is not in the data yet.
Ask this document
Answers come only from this document’s own text, as highlighted quotes. If it doesn’t say, you are told so instead of given a guess. Only its metadata is loaded so far, so most questions will be declined.
Try
Grants 8
- Targeting pyrimidine biosynthesis in pancreatic ductal adenocarcinoma F30CA265277↗
- Targeting Tumor-Stromal Metabolic Cross-Talk in Pancreatic Cancer R01CA163649↗
- Targeting the Metabolic Basis of Cachexia in Pancreatic Cancer R01CA210439↗
- Metabolic Regulation of Tumor Progression, Metastasis and Chemoresistance by SIRT5/ELK3 signaling in Pancreatic Cancer R01CA216853↗
- Mitochondrial calcium signaling in pancreatic cancer metastasis and progression R01CA256911↗
- Molecular Basis of ME2-mediated Tumor Suppression in Pancreatic Cancer R01CA270234↗
- Cancer Biology Training Program T32CA009476↗
- MUC1 in Therapy Resistance U54CA274329↗